Lidocaine Nerve Block Reduces Pain During IUD Insertion

Share this content:
Lidocaine Nerve Block Reduces Pain During IUD Insertion
Lidocaine Nerve Block Reduces Pain During IUD Insertion

MONDAY, Sept. 11, 2017 (HealthDay News) -- A 10-mL 1 percent lidocaine paracervical nerve block reduces pain during intrauterine device (IUD) insertion, according to a study published online Sept. 5 in Obstetrics & Gynecology.

Aletha Y. Akers, M.D., M.P.H., from Children's Hospital of Philadelphia, and colleagues randomized 95 adolescents and young women (ages 14 to 22) receiving a 13.5-mg levonorgestrel IUD to either a 10-mL 1 percent lidocaine paracervical block or a sham block (1 cm depression of the vaginal epithelium at paracervical block sites with a wooden cotton-tipped applicator).

The researchers found that 79 percent of the study participants previously used contraception. After IUD insertion, the median visual analog scale score was significantly lower in the lidocaine block group compared with the sham block group (30 versus 71.5).

"The 1 percent paracervical nerve block may be useful for reducing patient-reported pain during IUD insertion, but its use must be balanced with a careful consideration of the risks associated with this nerve blockade," conclude the authors.

Several authors report financial ties to the pharmaceutical industry, and one author trains health care providers to insert the Nexplanon contraceptive device as a consultant for Merck. Bayer Healthcare Inc. provided funding for the study.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »